Supplier profile
PPD DEVELOPMENT LP
Every public-sector award we hold for this supplier, across the United States, from 1 Nov 2011 to 30 Sept 2026.
Awards won
53
all time
Attributed value
$1.1bn
as published
Buyers
7
public bodies
Active
2011–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| National Institutes of Health | 37 | $794.2m |
| Defense Health Agency | 4 | $11.2m |
| Office of Assistant Secretary for Preparedness and Response | 4 | $251.5m |
| Department of the Army | 3 | $2.3m |
| Food and Drug Administration | 3 | $2.3m |
| Centers for Disease Control and Prevention | 1 | $2.1m |
| NATIONAL INSTITUTES OF HEALTH NIAID | 1 | $48.0m |
What they win
Awards
Showing 1–25 of 53 awards we hold
- VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES ↗NATIONAL INSTITUTES OF HEALTH NIAID£48.0mawarded 30 Sept 2026
- Task Order Award- Phase I Clinical Trials For The Development Of Neurotherapeutics- Dti-117 In Healthy Volunteers/Sad And Mad Ct ↗National Institutes of Health£2.0mawarded 26 Jun 2026
- Daids Monitoring For 1 Phase Iii Study: A5300b/I2003b (Phoenix) ↗National Institutes of Health£3.1mawarded 10 Dec 2025
- Task Order75n95025f00001 To4 Blueprint Medtech Preparation Of Pre-Submission Support For Pilot Participant. ↗National Institutes of Health£5kawarded 20 Dec 2024
- Baa-Fy24c3cp5-Understanding Heterogeneity In Preferences For Clinical Trial Participation In Diverse Patient Populations. ↗Food and Drug Administration£1.3mawarded 24 Sept 2024
- Fdabaa-24-00123, Ref # Fy24c1ep6, Cardiovascular-Kidney-Metabolic (Ckm) Syndrome Patient-Reported Outcome (Pro) Burden Measure ↗Food and Drug Administration£724kawarded 11 Sept 2024
- Comprehensive And Rapid Response For Niaid Research Programs Hiv And Other Infectious Diseases Clinical Research Support Services (Crss) ↗National Institutes of Health£26.1mawarded 7 Aug 2024
- Phase I Randomized Double-Blind Placebo-Controlled Study To Assess Safety, Tolerability, And Pharmacokinetics ↗National Institutes of Health£306kawarded 15 Jul 2024
- First In Human Randomized, Double-Blind, Placebo Controlled Single Ascending Dose (Sad) Phase I Study ↗National Institutes of Health£2.8mawarded 1 Jul 2024
- Research And Development For Clinical Studies In The Blueprint Medtech. Clinical Study Protocol Development. Task Order 02. 06/17/2024 - 06/16/2029. Base And Exercise 2 Units Of Option Quantity 1. ↗National Institutes of Health£324kawarded 17 Jun 2024
- Regulatory Consulting Assistance For Medical Device Developer. Research And Development For Clinical Studies In The Blueprint Medtech. Pre-Submission Assessment & Package Preparation. Task Order 03. 04/09/2024 - 04/08/2029. ↗National Institutes of Health£371kawarded 9 Apr 2024
- Niaid Clinical Site Monitoring (Ncsm) ↗National Institutes of Health£73.2mawarded 24 Jan 2024
- Barda Will Implement A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial In The US To Evaluate The Safety And Efficacy Of Novel Host-Directed Therapeutic Candidates In Hospitalized Adults With Ards. ↗Office of Assistant Secretary for Preparedness and Response£117.4mawarded 15 Dec 2023
- Advanced Research And Development Activities For Novel Immunogenicity Assays And Sample Collection Technologies As Part Of Barda?s Continuing Support For Covid-19 Vaccine Development, Assessing Impact Of Variants On Vaccine Immunogenicity, And Analyz ↗Office of Assistant Secretary for Preparedness and Response£126.5mawarded 29 Sept 2023
- Assessing Clinical Site Readiness: A Framework To Support Enrollment Of Under-Represented Minorities In Medical Device Clinical Trials (Fy23c1fwp6) ↗Food and Drug Administration£235kawarded 27 Sept 2023
- Regulatory Consulting Assistance For Medical Device Developer. Research And Development For Clinical Studies In The Blueprint Medtech. Task Order 02. 09/15/2023 - 09/14/2024. ↗National Institutes of Health£64kawarded 15 Sept 2023
- Clinical Site And Study Monitoring For Research Partnerships For Global Mental Health. ↗National Institutes of Health£93kawarded 14 Sept 2023
- EPCTU ↗National Institutes of Health£2.8mawarded 29 Jun 2023
- The Continuum Of Care In Hospitalized Patients With Opioid Use Disorder And Infectious Complications Of Drug Use (Choice) ↗National Institutes of Health£2.3mawarded 26 Sept 2022
- Clinical Research And Study Monitoring Support For Nimh Studies ↗National Institutes of Health£1.2mawarded 23 Sept 2022
- "covid 19"completion Of Activ 2 Study ↗National Institutes of Health£64.0mawarded 23 Sept 2022
- Task 1 (Preparation Of Medical Device Pre-Submission): Prepare Pre-Submission For Fda Feedback About The Medical Device Being Studied.fy22. Pop: 9/21/22 - 9/20/23 ↗National Institutes of Health£22kawarded 20 Sept 2022
- Military Medical Research And Development Services ↗Defense Health Agency£3kawarded 8 Sept 2022
- Task Order 1a Project Kick-Off Meeting ↗National Institutes of Health£2kawarded 21 Jul 2022
- National Institute Of Allergy And Infectious Diseases (Niaid) Clinical Site Monitoring Center (Csmc) ↗National Institutes of Health£36.4mawarded 23 May 2022
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.